Alicia Morgans, MD, MPH Member, Board of Directors Dana-Farber Cancer Institute Dr. Morgans is an Associate Professor of Medicine at Harvard Medical School, a Genitourinary Medical Oncologist and the Director of the Survivorship Program at Dana-Farber Cancer Institute. As a clinician and investigator, she has expertise in clinical trials and patient-reported outcome measures, as well as incorporating patient preferences and beliefs into clinical decision making. Her research has investigated complications of systemic therapy for prostate cancer survivors, including the study of skeletal, cardiovascular, diabetic, and cognitive complications, and her work has been funded by grants from the Prostate Cancer Foundation, the National Comprehensive Cancer Network, and the Department of Defense. She leads multiple therapeutic and quality of life focused clinical trials for prostate cancer patients, and has participated in the advanced and localized prostate cancer treatment guidelines committees of the American Urologic Association, and the cardio-oncology committee of American Heart Association. More from Alicia Videos & Webinars Survivorship: Living Beyond a Prostate Cancer Diagnosis Dr. Alicia Morgans discusses prostate cancer treatments and how to mitigate side effects through lifestyle changes. Prostate Cancer News Educating Patients and Caregivers About Prostate Cancer Dr. Alicia Morgans emphasizes the importance of educating prostate cancer patients and caregivers through trusted resources, like the Prostate Cancer Foundation and ZERO Prostate Cancer, and encourages open communication with medical teams, addressing topics such as cancer curability, treatment options, sexual health, mental health, and the need for support in the context of prostate cancer care. Videos & Webinars Living Well with Prostate Cancer: Survivorship Dr. Alicia Morgans explores medical and psychological complications of prostate cancer, from cardiovascular concerns to cognitive impacts. View all
Dr. Morgans is an Associate Professor of Medicine at Harvard Medical School, a Genitourinary Medical Oncologist and the Director of the Survivorship Program at Dana-Farber Cancer Institute. As a clinician and investigator, she has expertise in clinical trials and patient-reported outcome measures, as well as incorporating patient preferences and beliefs into clinical decision making. Her research has investigated complications of systemic therapy for prostate cancer survivors, including the study of skeletal, cardiovascular, diabetic, and cognitive complications, and her work has been funded by grants from the Prostate Cancer Foundation, the National Comprehensive Cancer Network, and the Department of Defense. She leads multiple therapeutic and quality of life focused clinical trials for prostate cancer patients, and has participated in the advanced and localized prostate cancer treatment guidelines committees of the American Urologic Association, and the cardio-oncology committee of American Heart Association.
More from Alicia Videos & Webinars Survivorship: Living Beyond a Prostate Cancer Diagnosis Dr. Alicia Morgans discusses prostate cancer treatments and how to mitigate side effects through lifestyle changes. Prostate Cancer News Educating Patients and Caregivers About Prostate Cancer Dr. Alicia Morgans emphasizes the importance of educating prostate cancer patients and caregivers through trusted resources, like the Prostate Cancer Foundation and ZERO Prostate Cancer, and encourages open communication with medical teams, addressing topics such as cancer curability, treatment options, sexual health, mental health, and the need for support in the context of prostate cancer care. Videos & Webinars Living Well with Prostate Cancer: Survivorship Dr. Alicia Morgans explores medical and psychological complications of prostate cancer, from cardiovascular concerns to cognitive impacts. View all
